A Blessing or a Curse for RA Patients?
Xeljanz, approved by the FDA in 2012, is a first-in-class drug to treat rheumatoid arthritis.
But is it safe? Check out my latest Healthline article, here =>
http://www.healthline.com/health-news/xeljanz-blessing-or-curse-for-ra-patients-100414